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RNA interference (RNAi) is a strategy of gene regulation that has opened up many
opportunities for the treatment of cancers, especially glioblastoma multiforme
(GBM). This strategy reduced the expression of many proteins involved in the
resistance of these tumors to anticancer drugs, particularly to temozolomide
(TMZ). A significant research effort has gone into RNAi delivery and target
selection for clinical application of this new discovery in the treatment of GBMs.
However, some limitations must be resolved to enhance the safety of RNAi-based
therapeutics and to reduce their immune response. In this review, the mechanism
of RNAi will be described. Moreover, the opportunities offered by RNAi strategy to
reverse the phenotype of these tumor cells as well as prospects and challenges
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